MedPath

Effectiveness of Drotaverine HCL in reducing the duration of first stage of labour among nulliparous women at Federal Teaching Hospital, Abakaliki.

Phase 1
Conditions
Pregnancy and Childbirth
Registration Number
PACTR201810902005232
Lead Sponsor
Ikeotuonye Arinze
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Female
Target Recruitment
220
Inclusion Criteria

Nullipara or primigravida
Cervical dilation of 4-5cm only
Consent
No prior use of spasmolytics

Exclusion Criteria

Term PROM
Coexisting masses
Allergy to Drotaverine HCL
Multipara
Postdatism

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Ā© 2025 MedPath, Inc. All rights reserved.